825 - Zero PSA after RP: It is reasonable in selected N+ prostate cancer patients if a ePLND is performed
| Autor: | Ramirez Backhaus, M., Mir Maresma, C., Mascarós, J.M., Mamber, A., Gómez-Ferrer, Á., Domínguez-Escrig, J.L., Casanova, J.L., Iborra, I., Monrós, J.L., Collado Serra, A., Hernández, J., Spinetti, G., Calatrava Fons, A., Rubio-Briones, J. |
|---|---|
| Zdroj: | In European Urology Supplements March 2018 17(2):e1177-e1177 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect